Drug: gemcitabine Quarter: 2016Q3
Total Records: 1,060 Number of Pages: 53
DRUGNAME | PT | EventCount |
---|---|---|
GEMCITABINE | Tumour lysis syndrome | 1 |
GEMCITABINE | Tumour necrosis | 1 |
GEMCITABINE | Tumour rupture | 1 |
GEMCITABINE | Upper respiratory tract infection | 1 |
GEMCITABINE | Urinary retention | 1 |
GEMCITABINE | Urinary tract disorder | 1 |
GEMCITABINE | Urinary tract pain | 1 |
GEMCITABINE | Urine protein/creatinine ratio increased | 1 |
GEMCITABINE | Urticaria | 1 |
GEMCITABINE | Uterine haemorrhage | 1 |
GEMCITABINE | Vaginal haemorrhage | 1 |
GEMCITABINE | Vaginal perforation | 1 |
GEMCITABINE | Vanishing bile duct syndrome | 1 |
GEMCITABINE | Vascular access complication | 1 |
GEMCITABINE | Ventricular hypokinesia | 1 |
GEMCITABINE | Vertebral column mass | 1 |
GEMCITABINE | Vertigo | 1 |
GEMCITABINE | Vision blurred | 1 |
GEMCITABINE | White blood cell count abnormal | 1 |
GEMCITABINE | White blood cell count increased | 1 |
Total Records: 1,060 Number of Pages: 53